Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Cash Flows

v3.8.0.1
Consolidated Statement of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Net income (loss) $ 1,847,000 $ 8,463,000
Adjustments to reconcile net income to cash provided by operating activities:    
Amortization and depreciation 20,084,000 6,899,000
Impairment of IPR&D assets 0  
Provision for losses on accounts receivable 0 87,000
Amortization of investment premiums 0 47,000
Amortization of Debt Issuance Costs and Discounts 287,000 0
Stock-based compensation 8,473,000 5,474,000
Deferred income taxes (2,332,000) 155,000
Gain on disposal of property and equipment 0 (88,000)
(Gain) loss on foreign currency 471,000 (216,000)
Excess tax benefits on stock-based awards (797,000) (914,000)
Changes in operating assets and liabilities:    
Accounts receivable (24,533,000) (7,436,000)
Inventory 7,676,000 (5,102,000)
Prepaid expenses and other assets 1,003,000 825,000
Accounts payable, accrued expenses and other current liabilities (421,000) 7,952,000
Accrued compensation 2,502,000 382,000
Deferred revenue and deferred profit (138,000) (307,000)
Accrued price protection liability (1,359,000) 6,771,000
Other long-term liabilities (792,000) (320,000)
Net cash provided by operating activities 11,971,000 22,672,000
Investing Activities    
Purchases of property and equipment (2,381,000) (743,000)
Purchases of intangible assets 0 (120,000)
Purchases of available-for-sale securities 0 (30,577,000)
Maturities of available-for-sale securities 0 20,785,000
Net cash used in investing activities (2,381,000) (10,655,000)
Financing Activities    
Repurchases of common stock 0 (334,000)
Net proceeds from issuance of common stock 980,000 361,000
Minimum tax withholding paid on behalf of employees for restricted stock units (2,391,000) (4,903,000)
Repayments of Secured Debt (25,000,000) 0
Net cash used in financing activities (26,411,000) (4,876,000)
Effect of exchange rate changes on cash and cash equivalents (258,000) 1,201,000
Increase (decrease) in cash, cash equivalents and restricted cash (17,079,000) 8,342,000
Cash, cash equivalents and restricted cash at beginning of period 74,412,000 82,896,000
Cash, cash equivalents and restricted cash at end of period 57,333,000 91,238,000
Supplemental disclosures of cash flow information:    
Cash paid for interest 3,546,000 0
Cash paid for income taxes 203,000 421,000
Issuance of accrued share-based bonus plan 6,997,000 3,314,000
Physpeed [Member]    
Supplemental disclosures of cash flow information:    
Issuance of restricted stock units to Physpeed continuing employees $ 0 $ 861,000